EL ESTEE LAUDER COMPANIES INC
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1001250 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.8%
TTM net income YoY139.6%
TTM EPS YoY139.0%
Revenue 3-yr CAGR-0.5%
Net income 3-yr CAGR-12.9%
Margins
Gross margin76.0%
Operating margin6.7%
Net margin2.4%
FCF margin9.9%
EBITDA margin11.8%
Returns
ROE9.3%
ROA1.9%
ROIC (approx.)6.1%
Asset turnover0.78x
Leverage & solvency
Liabilities / assets79.8%
Debt / equity1.67x
Current ratio1.25x
Interest coverage3.08x
Cash quality & payout
Operating cash flow / net income5.29x
Accruals ratio-8.0%
Payout ratio137.8%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2026Q22025-12-31 | 2026Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.71B | $3.63B | $3.71B | $4.23B | $3.48B | $3.41B | $3.55B | $4.00B |
| Cost of revenue | $902.00M | $890.00M | $876.00M | $994.00M | $927.00M | $955.00M | $889.00M | $957.00M |
| Gross profit | $2.81B | $2.74B | $2.84B | $3.23B | $2.55B | $2.46B | $2.66B | $3.05B |
| SG&A expense | $2.37B | $2.48B | $2.28B | $2.63B | $2.30B | $2.31B | $2.26B | $2.58B |
| Operating income | $408.00M | -$39.00M | $249.00M | $401.00M | $169.00M | -$390.00M | $306.00M | -$580.00M |
| Interest expense | $83.00M | $81.00M | $82.00M | $85.00M | $86.00M | $88.00M | $87.00M | $90.00M |
| Pretax income | $345.00M | -$104.00M | $179.00M | $333.00M | $109.00M | -$451.00M | $241.00M | -$650.00M |
| Income tax | $112.00M | $12.00M | $90.00M | $171.00M | $62.00M | $95.00M | $82.00M | -$60.00M |
| Net income | $233.00M | -$116.00M | $89.00M | $162.00M | $47.00M | -$546.00M | $159.00M | -$590.00M |
| EBITDA | $599.00M | $159.00M | $450.00M | $598.00M | $369.00M | -$180.00M | $510.00M | -$373.00M |
| EPS (basic) | 0.64 | — | 0.25 | 0.45 | 0.13 | — | 0.44 | -1.64 |
| EPS (diluted) | 0.64 | — | 0.24 | 0.44 | 0.13 | — | 0.44 | -1.64 |
| Dividends declared per share | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
| Weighted avg. shares (diluted) | 366.10M | — | 365.40M | 364.80M | 363.30M | — | 361.40M | 360.00M |
| Balance sheet | ||||||||
| Cash & equivalents | $3.20B | $3.50B | $3.13B | $3.08B | $2.22B | $2.92B | $2.63B | $2.59B |
| Receivables | $1.91B | $1.52B | $1.75B | $1.66B | $1.88B | $1.53B | $1.79B | $1.61B |
| Inventory | $2.15B | $2.00B | $1.92B | $1.90B | $2.06B | $2.07B | $1.96B | $2.00B |
| Current assets | $7.82B | $7.61B | $7.50B | $7.16B | $6.71B | $7.07B | $7.02B | $6.90B |
| PP&E, net | $2.71B | $2.81B | $2.85B | $2.97B | $3.06B | $3.17B | $3.06B | $3.05B |
| Goodwill | $2.11B | $2.11B | $2.12B | $2.14B | $2.12B | $2.13B | $2.08B | $2.07B |
| Intangibles | $3.58B | $3.58B | $3.63B | $3.70B | $3.71B | $3.76B | $4.13B | $4.16B |
| Total assets | $19.96B | $19.76B | $19.66B | $19.63B | $19.33B | $19.89B | $19.89B | $19.76B |
| Current liabilities | $6.25B | $6.23B | $5.91B | $5.27B | $5.08B | $5.43B | $4.96B | $5.03B |
| Short-term debt | — | $503.00M | — | — | — | $3.00M | — | — |
| Long-term debt | $6.75B | $6.80B | $6.81B | $7.32B | $7.32B | $7.31B | $7.30B | $7.28B |
| Total debt | $6.75B | $7.31B | $6.81B | $7.32B | $7.32B | $7.32B | $7.30B | $7.28B |
| Total liabilities | $15.93B | $15.96B | $15.67B | $15.60B | $15.44B | $16.03B | $15.54B | $15.59B |
| Shareholders' equity | $4.04B | $3.81B | $3.99B | $4.03B | $3.89B | $3.87B | $4.34B | $4.17B |
| Net debt | $3.55B | $3.81B | $3.68B | $4.24B | $5.10B | $4.40B | $4.67B | $4.69B |
| Cash flow statement | ||||||||
| Operating cash flow | -$166.00M | $576.00M | $412.00M | $1.12B | -$340.00M | $601.00M | $284.00M | $1.06B |
| Capital expenditure | $69.00M | $151.00M | $102.00M | $108.00M | $96.00M | $207.00M | $122.00M | $132.00M |
| Free cash flow | -$235.00M | $425.00M | $310.00M | $1.02B | -$436.00M | $394.00M | $162.00M | $925.00M |
| Investing cash flow | -$61.00M | -$185.00M | -$96.00M | -$92.00M | -$116.00M | -$215.00M | -$114.00M | -$134.00M |
| Financing cash flow | -$80.00M | -$30.00M | -$263.00M | -$180.00M | -$239.00M | -$128.00M | -$138.00M | -$652.00M |
| Depreciation & amortization | $191.00M | $198.00M | $201.00M | $197.00M | $200.00M | $210.00M | $204.00M | $207.00M |
| Stock-based compensation | $70.00M | $56.00M | $72.00M | $94.00M | $88.00M | $49.00M | $75.00M | $106.00M |
| Dividends paid | $126.00M | $127.00M | $126.00M | $128.00M | $127.00M | $126.00M | $126.00M | $126.00M |
| Share buybacks | $1.00M | $0 | $3.00M | $58.00M | $9.00M | $0 | $0 | $25.00M |
Free plan shows the latest 8 periods; Pro shows all 69 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.